Monday, December 12, 2016

FDA Affirms Bladder Cancer Warning for Pioglitazone

(MedPage Today) -- Agency unpersuaded by manufacturer-sponsored study asserting no risk
via FDA Affirms Bladder Cancer Warning for Pioglitazone
by

No comments:

Post a Comment